July 29, 2019 / 10:27 PM / a month ago

Oncologists appeal dismissal of Medicare drug reimbursement cut lawsuit

A group of oncologists on Monday urged a federal appeals court to revive a lawsuit challenging a “harmful and indiscriminate” 2% cut to Medicare reimbursements for medications including cancer drugs that are administered by healthcare providers.

The Community Oncology Alliance (COA) argued in a brief filed with the U.S. Court of Appeals for the District of Columbia Circuit that a judge had wrongly held the law governing Medicare Part B drug reimbursement rates barred its claims.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/30Z18Ys

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below